Provide feedbackProvide feedback
Home :: Pulmonary/Respiratory

A consistent response to bronchodilators over time associated with poor clinical outcomes in children, researchers find

Tuesday, December 16 2008 | Comments
Evidence Grade 2 What's This?

Researchers recently identified certain clinical parameters in children that are associated with a consistent response to inhaled beta-2 agonists, a phenotype they found to be linked with poor clinical outcomes. The investigators explained that bronchodilator response (BDR) to inhaled beta-2 agonists among individuals with asthma is variable and that the significance of a consistent response over time is unknown. Therefore, they sought to determine which baseline clinical variables predict...

Researchers recently identified certain clinical parameters in children that are associated with a consistent response to inhaled beta-2 agonists, a phenotype they found to be linked with poor clinical outcomes.

The investigators explained that bronchodilator response (BDR) to inhaled beta-2 agonists among individuals with asthma is variable and that the significance of a consistent response over time is unknown. Therefore, they sought to determine which baseline clinical variables predict a consistent response to inhaled beta-2 agonists and which clinical outcomes might be associated with this phenotype. To do so, they analyzed data from 1,041 children with mild to moderate asthma participating in the Childhood Asthma Management Program (CAMP). The children were followed for an average of 4.3 years and underwent lung function studies and completed questionnaires at regular intervals during that time.

Consistent BDR was defined as a response of >=12% of the control value and a concomitant increase of 200 mL at each annual follow-up visit. The children who did not achieve either of these criteria were designated as nonresponders.

There were 52 children who had consistent BDRs during the 4-year trial. Several factors were identified that were baseline predictors of a consistent BDR, including lower baseline prebronchodilator forced expiratory volume in 1 second values (odds ratio [OR], 0.71; 95% CI, 0.63-0.81; P<.0001), higher log10 IgE levels (OR, 1.97; 95% CI, 1.18-3.30; P=.002), and lack of treatment with inhaled corticosteroids (OR, 0.31; 95% CI, 1.13-0.75; P=.009).

The researchers also found that children with a consistent BDR had significantly more hospital visits than children who were classified as nonresponders (relative rate [RR], 1.80; 95% CI, 1.20-2.80; P=.007). Children with a consistent BDR status also required more prednisone bursts (RR, 1.52; 95% CI, 1.20-1.95; P=.0007), had increased nocturnal awakenings caused by asthma (RR, 1.40; 95% CI, 1.20-1.65; P<.0001), and missed more days of school (RR, 1.43; 95% CI, 1.03-1.99; P=.03) relative to the nonresponders.

The researchers stated that a consistently positive response to inhaled bronchodilators should prompt physicians to reevaluate their patient's asthma medication regimens.

"Although this study sheds light on some of the clinical variables that contribute to the variability in response to inhaled bronchodilators, it is clear that other predictors not captured in our model are involved," the investigators added. "A better understanding of genetic predictors, environmental exposures, and gene-environment interactions is required to fully account for the heterogeneity in response to asthma medications." (Sharma S, et al. J Allergy Clin Immunol 2008;122:921-8.)

Latest News

Adding certain spirometric measures to symptom history, beta-2-agonist use for assessing asthma severity useful, researchers suggest Verusmed

Monday, December 15 2008 | Comments
Evidence Grade 11 What's This?
New data suggest a majority of adolescents with asthma have normal lung function even though they experience significant asthma symptoms. However, when assessing the disease, the addition of certain spirometric parameters to symptom history appears to alter severity classifications.

Researchers noted that whether or not an assessment of lung function aids in determining asthma severity remains unclear, particularly among children and adolescents. So they designed a study to...
Tags: Asthma


ACCI valid measurement tool for assessing asthma disease status in both black, white subjects, study finds Verusmed

Monday, December 01 2008 | Comments
Evidence Grade 11 What's This?
In a recent study that evaluated the psychometric properties of the Asthma Control and Communication Instrument (ACCI)--a measure designed to capture patient-reported disease status during regular visits--researchers found it to be a "promising clinical tool" for assessing asthma disease status, with validity in both black and white subjects.

"Differences in assessment of asthma and in the quality of asthma care received have been implicated as contributing factors to...
Tags: Asthma


Atorvastatin as add-on therapy to ICSs offers no short-term improvement in asthma control, researchers report Verusmed

Monday, December 01 2008 | Comments
Evidence Grade 2 What's This?
Adults with mild to moderate atopic asthma who use inhaled corticosteroids (ICSs) experience no short-term improvement in asthma control with the addition of atorvastatin, although it does appear to reduce sputum macrophage counts, new data demonstrate.

The authors explained that in addition to cholesterol-lowering properties,  statins also have anti-inflammatory effects.  Results of one investigation showed that patients with rheumatoid arthritis who were treated...
Tags: Asthma


Breastfeeding for 4 months or more enhances children's lung volume, cohort study suggests Verusmed

Wednesday, November 19 2008 | Comments
Evidence Grade 2 What's This?
An infant who is breastfed for 4 months or more may benefit from improved lung volume at age 10 years, a new study concludes.

Researchers in the United States and United Kingdom teamed together to study the protective effects of breastfeeding; they specifically evaluated the relationship between breastfeeding duration and later lung volume.

The study population was drawn from the Isle of Wight birth cohort (n=1,456), a largely white (99%) group of children...
Tags: Asthma